Treatment with tirzepatide slowed the decline in the estimated glomerular filtration rate (eGFR) and reduced the urine albumin-creatinine ratio (UACR) in a clinically meaningful way compared with insulin glargine
Maddalena, G, van der Pol, Y, Rivers, Z, Dasari, NV, Rogers, JE, Guinney, J, Kopetz, S , Raghav, KS
Like GLP-1, both CAP-induced TRPV1 inward currents and Ca 2+ responses were decreased by 85% and 90.6%, respectively (Fig
It reflects a much more targeted understanding of the needs of GLP-1 users, particularly around satiety, protein adequacy and smaller eating occasions
Most users report noticeable improvements in skin quality within 4 weeks and enhanced recovery from the metabolic stress of caloric restriction by week 6